Publicaciones en colaboración con investigadores/as de Instituto Cajal (14)

2021

  1. Genetic deletion of dopamine D1 receptors increases the sensitivity to cannabinoid CB1 receptor antagonist-precipitated withdrawal when compared with wild-type littermates: studies in female mice repeatedly exposed to the Spice cannabinoid HU-210

    Psychopharmacology, Vol. 238, Núm. 2, pp. 551-557

2016

  1. Spinal cord compression injury in lysophosphatidic acid 1 receptor-null mice promotes maladaptive pronociceptive descending control

    European Journal of Pain (United Kingdom), Vol. 20, Núm. 2, pp. 176-185

2014

  1. The systemic administration of oleoylethanolamide exerts neuroprotection of the nigrostriatal system in experimental Parkinsonism

    International Journal of Neuropsychopharmacology, Vol. 17, Núm. 3, pp. 455-468

2011

  1. Distribution of diacylglycerol lipase alpha, an endocannabinoid synthesizing enzyme, in the rat forebrain

    Neuroscience, Vol. 192, pp. 112-131

  2. Estradiol decreases cortical reactive astrogliosis after brain injury by a mechanism involving cannabinoid receptors

    Cerebral Cortex, Vol. 21, Núm. 9, pp. 2046-2055

2009

  1. Sex-dependent alterations in response to maternal deprivation in rats

    Psychoneuroendocrinology, Vol. 34, Núm. SUPPL. 1

2008

  1. Expression and function of CB1 receptor in the rat striatum: Localization and effects on D1 and D2 dopamine receptor-mediated motor behaviors

    Neuropsychopharmacology, Vol. 33, Núm. 7, pp. 1667-1679

2007

  1. Cannabinoid CB1 receptor antagonism markedly increases dopamine receptor-mediated stereotypies

    European Journal of Pharmacology, Vol. 559, Núm. 2-3, pp. 180-183

2006

  1. Absence of quasi-morphine withdrawal syndrome in adenosine A2A receptor knockout mice

    Psychopharmacology, Vol. 185, Núm. 2, pp. 160-168

2003

  1. Neuroanatomical relationship between type 1 cannabinoid receptors and dopaminergic systems in the rat basal ganglia

    Neuroscience, Vol. 119, Núm. 1, pp. 309-318

2001

  1. Functional interaction between opioid and cannabinoid receptors in drug self-administration

    Journal of Neuroscience, Vol. 21, Núm. 14, pp. 5344-5350

  2. Role of the endogenous cannabinoid system as a modulator of dopamine transmission: Implications for Parkinson's disease and schizophrenia

    Neurotoxicity Research, Vol. 3, Núm. 1, pp. 23-35

1998

  1. CB1 cannabinoid receptor antagonist-induced opiate withdrawal in morphine-dependent rats

    NeuroReport, Vol. 9, Núm. 15, pp. 3397-3402

1996

  1. Colocalization of glucagon-like peptide-1 (GLP-1) receptors, glucose transporter GLUT-2, and glucokinase mRNAs in rat hypothalamic cells: Evidence for a role of GLP-1 receptor agonists as an inhibitory signal for food and water intake

    Journal of Neurochemistry, Vol. 67, Núm. 5, pp. 1982-1991